Home Assessment of critical values policies in Italian institutions: comparison with the US situation
Article
Licensed
Unlicensed Requires Authentication

Assessment of critical values policies in Italian institutions: comparison with the US situation

  • Elisa Piva , Laura Sciacovelli , Michael Laposata and Mario Plebani
Published/Copyright: February 4, 2010

Abstract

Background: Critical value reporting is considered an essential tool to ensure the quality of medical laboratory services. Important issues include defining cut-off values, assessing responsibility for communication and adopting information technology solutions to improve notification. Here, we report the state of critical value reporting in a large cohort of Italian laboratories and comparison with Q-Probes surveys from the College of American Pathologists as representatives of the US situation.

Methods: To compare critical value policies and procedures, formulation of critical values list with critical values limits and monitoring tools, a web-based questionnaire was formulated for 389 institutions participating in the External Quality Assessment Schemes of Veneto Region, in Italy.

Results: A total of 90 clinical laboratories submitted data. Accredited laboratories represented 82.2% of participants, but written procedures for reporting were indicated by 70.5% of participants. Relevant differences between US and Italian policies have been observed, particularly regarding who provides the notification and on the formulation of the cut-off threshold for critical values.

Conclusions: Accreditation according to international standards can decrease differences regarding the management of critical values across laboratories of different countries. However, the issues concerning critical limits should be debated and a consensus critical values list should be considered. Automated systems could offer improvements regarding some issues, such as who makes the notification, reducing the time spent in notification of critical values. Surveys for comparing and improving existing policies regarding critical values should be promoted at an international level.

Clin Chem Lab Med 2010;48:461–8.


Corresponding author: Prof. Mario Plebani, Dipartimento Medicina di Laboratorio, Azienda Ospedaliera-Università di Padova, Via Nicolò Giustiniani 2, 35128 Padova, Italy Fax: +39-049-663240,

Received: 2009-11-17
Accepted: 2009-11-24
Published Online: 2010-02-4
Published in Print: 2010-04-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Molecular biology and genetics in clinical chemistry and laboratory medicine
  3. Improving the post-analytical phase
  4. Reviews
  5. State of the art in therapeutic drug monitoring
  6. Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnostics
  7. Reference Values and Biological Variations
  8. Assessment of critical values policies in Italian institutions: comparison with the US situation
  9. Genetics and Molecular Diagnostics
  10. Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping
  11. Genotyping mitochondrial DNA single nucleotide polymorphisms by PCR ligase detection reactions
  12. FOXL2 mutations in Taiwanese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
  13. Low expression of human β-defensin 1 in duodenum of celiac patients is partially restored by a gluten-free diet
  14. General Clinical Chemistry and Laboratory Medicine
  15. Evaluation of C-reactive protein and serum amyloid A in the detection of inflammatory and infectious diseases in children
  16. Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays
  17. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer
  18. Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection
  19. Beware of carryover in modern chemistry analyzers
  20. Correlation between glucose and bupivacaine levels in cerebrospinal fluid after spinal anesthesia: glycorrhachia as predictor for duration of sensory block
  21. Comparison of different depletion strategies for improving resolution of the human urine proteome
  22. Cardiovascular Diseases
  23. Pregnancy-associated plasma protein-A as a marker for long-term mortality in patients with peripheral atherosclerosis: inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study
  24. Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals
  25. C-reactive protein variants are not associated with susceptibility to stroke and stroke recurrence
  26. Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart
  27. A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays
  28. Letters to the Editor
  29. High specificity but low sensitivity of the cartilage oligomeric matrix protein (COMP) test in rheumatoid arthritis and osteoarthritis
  30. Disparity in estimated average glucose due to different hemoglobin A1c methods and hemoglobin S trait
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.096/html
Scroll to top button